Does Reta Reduce Visceral Fat at All?

Weight loss of any kind trims visceral fat along with subcutaneous and lean mass. Reta should therefore cut visceral fat as weight drops. Its glucagon action may add a small extra effect compared with other GLP drugs, especially on liver fat, which often tracks with visceral stores. The biggest driver remains total weight reduction. Tesa does not produce weight loss but can shift fat away from visceral toward subcutaneous areas in the groups studied. Overall reta should deliver larger visceral fat changes than tesa if substantial weight comes off.

The glucagon part of reta was one reason I began splitting doses with tirz for visceral fat goals. Some tesa also arrived recently for the same purpose. I'll hold off on using it until I learn more and fix a back issue. Once that's resolved I'll add resistance training to my hiking and cardio, then bring tesa in.

If body fat percentage is still fairly high there is little need to focus on the exact type of fat being lost. Dropping five percent body fat will visibly change appearance and improve most biomarkers.

Sequential DEXA scans showed my visceral fat was strongly reduced by reta. I am now unsure whether I will even try the tesa I already have.

Both reta and tesa can reduce visceral fat, yet for most people it is the first fat to disappear anyway. If overweight, simply losing weight is enough and extra worry is unnecessary because visceral fat has more blood flow and receptors. Concern rises only when someone is already lean yet still carries high visceral levels.

All GLP-1 drugs reduce visceral fat more effectively than tesamorelin.

On my maintenance dose reta is gradually reducing stubborn subcutaneous belly fat. I have also added sit-ups and light weights.

Without DEXA or imaging you cannot actually see visceral fat. The current confusion around it likely stems from social media and limited education.

The glucagon fat-burning effect of reta does not activate strongly at very low doses. At those levels you mainly get tirzepatide-like results without the added unique action.

Visceral fat is among the first stores lost during weight reduction.

Better body composition comes from adding modest aerobic exercise to the calorie deficit created by reta or any GLP drug rather than relying on a drug alone. A daily 30-minute brisk walk outperforms tesamorelin or similar compounds without movement.

My scale shows progress from 15 down to 8 since May, confirming a downward trend even if it is less precise than DEXA.

My scale showed visceral fat dropping from 23 to 10. I am female, have not used any GH peptides, only other compounds, and combine walking, weight lifting, and reta since April 2025.

A tape measure offers a cheaper though less exact way to track changes. It captures both subcutaneous and visceral contributions yet waist circumference remains a useful health marker. Adding a small dose of HGH to reta or tirz produced an 8 cm waist drop with only 4 kg lost, versus 3 cm with 5 kg lost earlier, suggesting a higher proportion of intra-abdominal fat reduction.